Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
01/15/1986 | EP0168063A2 Peptide usable as an intermediate for the production of a physiologically active peptide |
01/15/1986 | EP0167852A2 Human interferon-gamma |
01/15/1986 | EP0167596A1 Anti-idiotype antibodies induced by synthetic polypeptides |
01/14/1986 | US4564593 Messenger RNA, production and use thereof |
01/14/1986 | US4564112 Closure cap for a container |
01/08/1986 | EP0167420A1 Expression vectors for factor IX, cells transformed with these vectors and process for the preparation of factor IX |
01/08/1986 | EP0167366A2 Accelerated nucleic acid reassociation method |
01/08/1986 | EP0167192A1 A process for the activation of promotors of bacteria |
01/08/1986 | EP0167006A2 Microbial degradation of obnoxious organic wastes into innocuous material |
01/08/1986 | EP0166996A1 A method for stabilizing a physiologically active substance produced by recombinant DNA technique and a stable aqueous solution or powder containing the same |
01/07/1986 | US4563424 Method and means for somatostatin protein conjugate expression |
01/07/1986 | US4563423 Products displaying the antigenicity of hepatitis B virus e antigens and methods of producing those antigens |
01/07/1986 | US4563419 Detection of microbial nucleic acids by a one-step sandwich hybridization test |
01/07/1986 | EP0094428A4 Control of dna sequence transcription. |
01/07/1986 | CA1198992A1 B.thuringiensis crystal protein in e.coli |
01/03/1986 | WO1986000139A1 Methods for the in vitro detection and identification of unknown pathogens or genetic entities |
01/03/1986 | WO1986000090A1 Hybrid protein and fused gene encoding gene |
01/03/1986 | WO1986000089A1 Eukarygotic hybrid vectors and preparation of polypeptides |
01/02/1986 | EP0166659A2 Transformation vector for yeast Yarrowia lipolytica, transformation process and transformed yeast |
01/02/1986 | EP0166628A1 Process for the amplification of the expression of a determined gene in bacillus subtilis and strains obtained |
01/02/1986 | EP0166585A2 Novel peptide and gene coding for same |
01/02/1986 | EP0166548A2 Broad spectrum vaccine against gonorrhea |
01/02/1986 | EP0166458A2 Monoclonal antibody capable of specifically distinguishing human hepato-carcinoma cells |
01/02/1986 | EP0166444A2 Fish growth hormone polypeptide |
01/02/1986 | EP0166410A2 Immunologically active peptides capable of inducing immunization against malaria and genes encoding therefor |
12/31/1985 | US4562159 Using labeled clones |
12/31/1985 | US4562156 Desulfurization of coal and petroleum products |
12/31/1985 | US4562155 Hybrid viral plasmid and microorganisms containing same |
12/31/1985 | US4562003 Diagnosis of respiratory distress syndrome |
12/31/1985 | CA1198693A1 Plasmid pcg2 |
12/27/1985 | EP0165830A1 Monoclonal antibodies to cytomegalovirus and methods for the diagnosis in vitro of infections by human cytomegaloviruses, using monoclonal antibodies which react with a cytomegalovirus-induced protein kinase |
12/27/1985 | EP0165811A2 Sialylated lewis X epitope, antibodies and diagnosis |
12/27/1985 | EP0165759A2 Mammalian promotors useful in yeast expression |
12/27/1985 | EP0165658A2 Methods and compositions for detection of legionnaires disease |
12/27/1985 | EP0165654A2 Purified interleukin 1 |
12/27/1985 | EP0165614A2 Hybrid plasmid and microorganism containing the same |
12/27/1985 | EP0165613A2 Process for controlling culture of recombinants |
12/27/1985 | EP0165313A1 Nucleic acid hybridization assay. |
12/24/1985 | US4560654 Microorganism with inserted dna fragment to controll production |
12/24/1985 | CA1198385A1 Optimal polypeptide production |
12/19/1985 | WO1985005690A1 Method and reactant for the differential determination of isoenzymes of the alkaline phosphatase and monoclonal antibody therefor |
12/19/1985 | WO1985005639A1 Distinguishing subsets of human cells |
12/19/1985 | WO1985005636A1 Trans-acting transcriptional factors |
12/19/1985 | WO1985005632A1 Chimeric plasmids that replicate in bacteria and yeast and microorganisms transformed therewith |
12/19/1985 | WO1985005631A1 Purifying recombinant dna products and checking product purity and efficiency of purification |
12/19/1985 | WO1985005629A1 Ltr vectors, methods of preparation and use |
12/19/1985 | WO1985005619A1 Novel polypeptide and process for its preparation |
12/19/1985 | WO1985005618A1 Process for preparing interferon derivative |
12/18/1985 | EP0165120A1 Lymphadenopathy-associated retrovirus adapted to continuous lymphoblastoid-B cell lines capable of continuously producing said retrovirus, and process for preparing the cell lines |
12/18/1985 | EP0165002A2 Recombinant DNA, microorganisms containing same and their use in the production of amylases |
12/18/1985 | EP0164992A2 Nitrogen fixation regulator genes |
12/18/1985 | EP0164965A2 Lymphotoxin, nucleic acid encoding it, vectors incorporating the nucleic acid and cells transformed therewith, methods of obtaining lymphotoxin, and lymphotoxin neutralizing antibody |
12/18/1985 | EP0164953A2 Preparation of monoclonal antibodies |
12/18/1985 | EP0164876A1 Displacement polynucleotide assay employing recombination protein and diagnostic kit |
12/18/1985 | EP0164754A1 Process for producing N-acetylneuraminate lyase |
12/18/1985 | EP0164719A2 Active site modified protease alpha-1-antitrypsin inhibitors and their production |
12/18/1985 | EP0164586A1 Nucleic acid probe coupled to radioactive label |
12/18/1985 | EP0164575A1 Transformation of plant genotype |
12/18/1985 | EP0164556A2 Enhanced yeast transcription employing hybrid promoter region constructs |
12/17/1985 | US4559308 Corynebacterium plasmid and vector |
12/17/1985 | US4559306 Modified Pasteurella multocida bacteria |
12/17/1985 | US4559302 Antibiotic resistant genes |
12/17/1985 | US4559300 Culturing |
12/17/1985 | CA1198071A1 Stabilization of a mutant microorganism population |
12/17/1985 | CA1198069A1 Temperature sensitive multicopy plasmids |
12/17/1985 | CA1198068A1 Bacterial polypeptide expression employing tryptophan promoter-operator |
12/17/1985 | CA1198067A1 Stable high copy number plasmids |
12/17/1985 | CA1198066A1 Production of human monoclonal antibodies by human hybridomas |
12/11/1985 | EP0164273A2 New peptide and gene coding for same |
12/11/1985 | EP0164245A2 Nif promoter of rhizobium japonicum |
12/11/1985 | EP0164176A2 Antigenic proteins and vaccines containing them and protective antibodies directed to them for prevention of coccidiosis caused by Eimeria tenella |
12/11/1985 | EP0164117A2 Amylase-negative, asporogenous mutant of Bacillus subtilis useful as a host in a host-vector system |
12/11/1985 | EP0164069A2 Process for the isolation and purification of alpha-interferons |
12/11/1985 | EP0164054A1 Method for detection of polymorphic restriction sites and nucleic acid sequences |
12/11/1985 | EP0163993A2 Structure and properties of modified interferons |
12/10/1985 | US4558010 Recombinant deoxyribonucleic acid which codes for plasminogen activator and method of making plasminogen activator protein therefrom |
12/10/1985 | US4558006 Immunoreactive with polypeptide sequence extant of erythropoietin; detecting red blood cell growth stimulating hormone |
12/10/1985 | CA1197797A1 Synthetic urogastrone gene, corresponding plasmid recombinants, transformed cells, production thereof and urogastrone expression |
12/05/1985 | WO1985005377A1 An efficient process for producing active chymosin from a precursor protein synthesized in bacteria |
12/05/1985 | WO1985005376A1 Vectors for the expression of factor ix and cell lineages producing the active factor ix |
12/04/1985 | EP0163603A1 A human T-Cell growth factor |
12/04/1985 | EP0163573A1 Site-specific proteolysis by renin |
12/04/1985 | EP0163529A1 Insulin precursors, process for their preparation and process for preparing human insulin from such insulin precursors |
12/04/1985 | EP0163493A2 Human monoclonal antibodies to serotypic lipopolysaccharide determinants on gram-negative bacteria and their production |
12/04/1985 | EP0163491A1 Yeast vector |
12/04/1985 | EP0163406A1 Novel polypeptide expression method |
12/04/1985 | EP0163304A2 Human monoclonal antibodies to intermediate filaments |
12/04/1985 | EP0163303A2 Human monoclonal antibodies to cell surface and intracellular antigens |
12/04/1985 | EP0163249A2 Gene-technological process for the preparation of human interleukin-2, and device for carrying out this process |
12/04/1985 | EP0163243A2 Improved human T or B cell lines and a process for producing immunologically active substances using the same |
12/04/1985 | EP0163220A2 Nucleic acid hybridization assay employing detectable anti-hybrid antibodies |
12/04/1985 | EP0163141A2 Monoclonal anti-human IgG antibody and process for preparing the same |
12/04/1985 | EP0163041A1 Diagnostic agent for heart disease and use thereof |
12/04/1985 | EP0162977A2 Enzyme immunoassay for cancer procoagulant |
12/04/1985 | EP0162920A1 Method of catalyzing chemical reactions |
12/04/1985 | EP0162898A1 Interleukin-2 production using cloned genes for interleukin-2 and yeast alpha-factor |
12/03/1985 | CA1197481A1 Recombinant dna |
11/27/1985 | EP0162812A2 Lymphokine in the pure state, monoclonal antibodies, hybridoma cell lines, processes and applications |
11/27/1985 | EP0162782A1 Expression vectors for factor IX, and cell lines producing the active factor IX |
11/27/1985 | EP0162757A1 Vaccine for rabies and process for its preparation |